Literature DB >> 7312745

Hypercalcaemia and phaeochromocytoma.

B J Fairhurst, S P Shettar.   

Abstract

A patient with a phaeochromocytoma associated with hypercalcemia is described. The hypercalcaemia was corrected by removal of the phaeochromocytoma. Parathyroid hormone-like peptide was isolated from the tumour suggesting that ectopic parathyroid hormone production from the phaeochromocytoma was the explanation of the hypercalcaemia.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7312745      PMCID： PMC2424967          DOI： 10.1136/pgmj.57.669.459

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  7 in total

1.  Normotensive phaeochromocytoma with hypercalcaemia: correction after adrenalectomy.

Authors:  R S Gray; J Gillon
Journal:  Br Med J       Date:  1976-02-14

2.  Phaeochromocytoma and hypercalcaemia.

Authors:  R R Ghose; H S Winsey; J Jemmett; J S Woodhead
Journal:  Postgrad Med J       Date:  1976-09       Impact factor: 2.401

Review 3.  Ectopic PTH syndrome, pseudohyperparathyroidism; hypercalcaemia of malignancy.

Authors:  R Buckle
Journal:  Clin Endocrinol Metab       Date:  1974-07

4.  Pheochromocytoma causing excessive parathyroid hormone production and hypercalcemia.

Authors:  S C Kukreja; G K Hargis; I M Rosenthal; G A Williams
Journal:  Ann Intern Med       Date:  1973-12       Impact factor: 25.391

5.  Hypercalcemia and familial pheochromocytoma. Correction after adrenalectomy.

Authors:  N W Swinton; E P Clerkin; L D Flint
Journal:  Ann Intern Med       Date:  1972-03       Impact factor: 25.391

6.  Parathyroid function in patients with pheochromocytoma.

Authors:  S S Miller; G W Sizemore; S G Sheps; G M Tyce
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

7.  Acute parathyroid hormone response to epinephrine in vivo.

Authors:  J A Fischer; J W Blum; U Binswanger
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808
  7 in total
  2 in total

1.  Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis.

Authors:  A Lasco; A Catalano; N Morabito; A Gaudio; G Basile; A Trifiletti; M Atteritano
Journal:  Osteoporos Int       Date:  2010-03-23       Impact factor: 4.507

2.  Malignant phaeochromocytoma and hypercalcaemia.

Authors:  J A Bridgewater; W A Ratcliffe; N J Bundred; C W Owens
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.